Below is a snapshot of the Web page as it appeared on 3/15/2023 (the last time our crawler visited it). This is the version of the page that was used for ranking your search results. The page may have changed since we last cached it. To see what might have changed (without the highlights), go to the current page.
Bing is not responsible for the content of this page.
ESG & sustainability info for Warner Chilcott, Inc. | ESG Ratings
Warner Chilcott, Inc. is a specialty pharmaceutical company focused on the women's healthcare and dermatology segments of the U.S. pharmaceutical market. The company has two facilities, one in Fajardo, Puerto Rico and the other in Larne, Northern Ireland. The Fajardo facility currently manufactures the majority of the women's healthcare products the company promotes, including Ovcon, Estrostep and Femcon, among others. The company was originally incorporated in Bermuda, then reincorporated in Ireland and has its headquarters in the US.